From the World Anti-Doping Agency
Montreal, 29 September 2016
Today, the World Anti-Doping Agency (WADA) publishes the 2017 List of Prohibited Substances and Methods; along with, the 2017 Summary of Major Modifications and Explanatory Notes. The List – which designates what substances and methods are prohibited both in- and out-of-competition, and which substances are banned in particular sports – was approved by the Executive Committee on 21 September and comes into force on 1 January 2017.
“WADA is pleased to publish the 2017 Prohibited List, which is one of five International Standards that are mandatory for all signatories of the World Anti-Doping Code (Code) to follow,” said WADA President, Sir Craig Reedie. “All athletes around the world are held to these standards and there can be no tolerance for people who intentionally break the rules,” Reedie continued. “Updated annually, the List is released three months ahead of taking effect so that all stakeholders – in particular athletes and their entourage — have ample time to familiarize themselves with the List and its modifications,” he said.
“The Prohibited List follows a very extensive stakeholder review process over the course of nine months,” said Director General, Olivier Niggli. “In reviewing the List, experts examine such sources as: scientific and medical research; trends; and, intelligence gathered from law enforcement and pharmaceutical companies in order to stay ahead of those that wish to cheat,” Niggli continued. “It is vital that all athletes take the necessary time to consult the List; and that, they contact their respective anti-doping organizations (ADOs) if they have any doubts as to the status of a substance or method,” said Niggli.
The List’s annual revision process is led by WADA, beginning with an initial meeting in January and concluding with the publication of the List by 1 October. This is an extensive nine-month consultation process which includes gathering information, circulating a draft list, stakeholder submissions, committee recommendations and the approval of the List by WADA’s Executive Committee during its September meeting.
It should be noted that, for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they can be accommodated via the International Standard for Therapeutic Use Exemptions (ISTUE), which has overwhelming acceptance from athletes, physicians and anti-doping stakeholders worldwide.
To view the changes made to the 2017 Prohibited List, please see the 2017 Summary of Major Modifications and Explanatory Notes.
Languages and Formats
As of today, the 2017 Prohibited List, the Summary of Modifications, and the 2017 Monitoring Program are available for download on WADA’s website in English. The French and Spanish will follow shortly.
Stakeholders wishing to translate the List into other languages are kindly asked to signal their interest at info@wada-ama.org, by 23 October.
As has been the case in past years, the List will be made available as an iPhone app and on other mobile devices effective 1 January 2017.
WADA MEDIA CONTACTS
Ben Nichols, Senior Manager, Media Relations and Communications
Phone: + 1-514-904-8225
E-mail: media@wada- ama.org
Maggie Durand, Coordinator, Media Relations and Communications
Phone: + 1-514-904-8225
E-mail: media@wada- ama.org
World ParaVolley contacts:
Louise Ashcroft, Medical Director
E-Mail: medicaldirector@worldparavolley.org
Jun Ming Zhang, Anti-Doping Commissioner
antidoping@worldparavolley.org